Browsing: DORTE

PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing a novel oral drug based on TRPV1 inhibition for treatment of obesity and diabetes, announces that a share purchase agreement was made between entities controlled by Dorte X. Gram, Chairman of the Board of PILA PHARMA AB